Abstract
SATB2-associated syndrome (SAS, glass syndrome, OMIM#612313) is a neurodevelopmental autosomal dominant disorder with frequent craniofacial abnormalities including palatal and dental anomalies. To assess the role of Satb2 in craniofacial development, we analyzed mutant mice at different stages of development. Here, we show that Satb2 is broadly expressed in early embryonic mouse development including the mesenchyme of the second and third arches. Satb2−/− mutant mice exhibit microglossia, a shortened lower jaw, smaller trigeminal ganglia, and larger thyroids. We correlate these findings with the detailed clinical phenotype of four individuals with SAS and remarkable craniofacial phenotypes with one requiring mandibular distraction in childhood. We conclude that the mouse and patient data presented support less well-described phenotypic aspects of SAS including mandibular morphology and thyroid anatomical/functional issues.
| Original language | English |
|---|---|
| Pages (from-to) | 209-213 |
| Number of pages | 5 |
| Journal | Clinical Genetics |
| Volume | 106 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.
Funding
This work was supported by NIH grant R15 DE026611 to JLF.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | R15 DE026611 |
Keywords
- SATB2
- SATB2-associated syndrome
- craniofacial anomalies
- pharyngeal arches
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)